ACHE and Alzheimer disease: Furthermore, the multiple targets of PIC exhibited AChE inhibitory activities (Figure 2B), anti-Aβ self-aggregation (Figure 2C), neuroprotection against Aβ(25–35)-induced cell deaths (Figure 2D), and antioxidant and anti-inflammation abilities [18,21], which might be beneficial in delaying the onset of AD.